Julie Kang Selected Research

Proto-Oncogene Proteins c-bcr

1/2020

Synthesis of imatinib, a tyrosine kinase inhibitor, labeled with carbon-14.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Kang Research Topics

Disease

3	Neoplasms (Cancer) 07/2020 - 12/2018
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Leukemia 01/2020
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Triple Negative Breast Neoplasms 12/2018
1	Parasitic Diseases (Parasitic Disease) 07/2012
1	Ectopic Pregnancy 09/2004

Drug/Important Bio-Agent (IBA)

1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Proto-Oncogene Proteins c-bcrIBA 01/2020
1	PlatinumIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Protons (Proton)IBA 01/2019
1	STA 9090IBA 12/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2018
1	Molecular Chaperones (Chaperone, Molecular)IBA 12/2018
1	Biological ProductsIBA 07/2012
1	Methotrexate (Mexate)FDA LinkGeneric 09/2004
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2004

Therapy/Procedure

2	Radiotherapy 01/2020 - 01/2019
1	Re-Irradiation 07/2020
1	Proton Therapy 01/2019
1	Therapeutics 12/2018